medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2021-35-12-18medalphabet-2353Research ArticleСТОМАТОЛОГИЯDENTISTRYРеабилитационные аспекты нутритивной коррекции после обширных сочетанных резекций кишечникаRehabilitation aspects of nutritional correction after extensive combined sequity resectionКостюченкоЛ. Н.KostyuchenkoL. N.

Костюченко Людмила Николаева - доктор медицинских наук, профессор, акад. РАЕ, рук. отдела нутрициологии.

Москва

Kostyuchenko Lyudmila N. - DM Sci (habil.), professor, academician of RANS, head of Nutrition Department.

Moscow

aprilbird2@ya.ruЛычковаА. Э.LychkovaA. E.

Лычкова Алла Эдуардовна - доктор медицинских наук, зав. по патентной и изобретательской работе.

Москва

Lychkova Alla. E. - MD, DSc, head of Patent and Inventive Work Department.

Moscow

ГБУЗ Московский клинический научно-практический центр имени А.С. Логинова Департамента здравоохранения МосквыРоссияMoscow Clinical Scientific and Practical Centre n. a. A.S. LoginovRussian Federation202118122021035Практическая гастроэнтерология (3)1218Copyright © Костюченко Л.Н., Лычкова А.Э., 20212021Костюченко Л.Н., Лычкова А.Э.Kostyuchenko L.N., Lychkova A.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2353Цель

Цель. Тактика нутриционной реабилитации после обширных резекций кишечника. Представлены метаболические характеристики синдрома короткой кишки и последствий сочетанных тонко-толстокишечных резекций, а также адаптивные и регенераторные возможности кишки. Приведена оптимальная схема нутритивной коррекции при последствиях сочетанных резекций кишечника.

Вывод

Вывод. Для стимуляции адаптивно-регенераторных процессов в кишечнике целесообразно использовать тедуглутид (аналог GLP-2), при неэффективности может быть рекомендована хирургическая реабилитация.

The purpose is the tactics of nutritional rehabilitation after extensive intestinal resection. The metabolic characteristics of the short intestine syndrome and the consequences of combined fine-binding resections, as well as the adaptive and regenerative capabilities of the bowel, are presented. The optimal scheme of nutritional correction for the consequences of combined bowel resections is presented.

Conclusion. To stimulate adaptive-regenerative processes in the intestine, it is advisable to use teduglutide (analogue of GLP-2); if ineffective, surgical rehabilitation can be recommended.

нутриционная реабилитациятедуглутидрезекция кишечникаnutritional rehabilitationteduglutideintestinal resectionReferencesПарентеральное и энтеральное питание: национальное руководство. Под ред. М. Ш. Хубутия, Т. С. Поповой, А. И. Салтанова. М.: ГЭОТАР-МЕДИА. 1-е изд-е, 2014. 800 с.Parenteral and enteral nutrition: national guidelines. Ed. M. Sh. Khubutia, T. S. Popova, A. I. Saltanov. M.: GEOTAR-MEDIA. 1st ed., 2014. 800 p.Jeppesen P. B. Spectrum of short bowel syndrom in adults: Intestinal insufficiency to Intestinal failure. JPEN J Parenter Enteral Nutr 2014; 38 (1 Suppl): 8S-13S.Jeppesen P. B. Spectrum of short bowel syndrom in adults: Intestinal insufficiency to Intestinal failure. JPEN J Parenter Enteral Nutr 2014; 38 (1 Suppl): 8S-13S.Очерки клинической энтерологии. Сборник статей сотрудников МКНЦ им. А. С. Логинова. Составители: Парфенов А. И., Князев О. В. Под. ред. И. Е. Хатькова. М.: 2021. 480 с.Essays on clinical enterology. Collection of articles by the staff of the Moscow Research Center of A. S. Loginov. Compiled by A. I. Parfenov, O. V. Knyazev. Ed. by I. E. Khatkov. Moscow: 2021. 480 p.Костюченко Л. Н. Нутрициология в онкологии пищеварительного тракта (избранные лекции). Под ред. Л. Н. Костюченко. М.: ООО «Компания БОРГЕС». 2019. 320 с.Kostyuchenko L. N. Nutrition in oncology of the digestive tract (selected lectures). Ed. By L. N. Kostyuchenko. M.: LLC «Company BORGES». 2019. 320 p.Darlene G Kelly, Kelly A Tappenden, Marion F Winkler Short bowel syndrome: highlights of patient management, quality of life, and survival JPEN J Parenter Enteral Nutr. 2014 May; 38 (4): 427–37.Darlene G Kelly, Kelly A Tappenden, Marion F Winkler Short bowel syndrome: highlights of patient management, quality of life, and survival JPEN J Parenter Enteral Nutr. 2014 May; 38 (4): 427–37.Tseng YS, Wu WB, Chen Y, Lo Yang F, Ma MC Small intestine resection increases oxalate and citrate transporter expression and calcium oxalate crystal formation in rat hyperoxaluric kidneys. Clin Sci (Lond). 2020 Oct 16; 134 (19): 2565–2580.Tseng YS, Wu WB, Chen Y, Lo Yang F, Ma MC Small intestine resection increases oxalate and citrate transporter expression and calcium oxalate crystal formation in rat hyperoxaluric kidneys. Clin Sci (Lond). 2020 Oct 16; 134 (19): 2565–2580.Костюченко Л. Н. Нутриционная поддержка при последствиях обширных резекций различных отделов кишечника. Современная медицинская наука, 2013. № 3. С. 48–67.Kostyuchenko L. N. Nutritional support in the aftermath of extensive bowel resec-tions. Modern medical science, 2013. No. 3. P. 48–67.В. А. Алмазов, Н. Н. Петрищев, Е. В. Шляхто, Н. В. Леонтьева. Клиническая пато-физиология: учеб. пособие для студентов мед. вузов. 1999. 464 с.V. A. Almazov, N. N. Petrishchev, E. V. Shlyakhto, N. V. Leontyev. Clinical patho-physiology: textbook. manual for students of honey. universities. 1999. 464 p.Эттингер А. П. Основы регуляции электрической и двигательной активности ЖКТ. РЖГГК. 1998. № 4. С. 13–17.Ettinger A. P. Fundamentals of the regulation of electrical and motor activity of the gastrointestinal tract. RZHGGK. 1998. No. 4. P. 13–17.Полева Н. И. Диагностика и лечение лактазной недостаточности при заболеваниях кишечника. Автореф. дисс. канд. мед. наук. Москва. 1995. 21 с.Poleva N. I. Diagnostics and treatment of lactase deficiency in bowel diseases. Abstract of thesis. diss. cand. med. sciences. Moscow. 1995. 21 p.O’Keefe S.J., Buchman AL, Fishbain TM et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin. Gastroenterol Hepatol 2006; 4 (1): 6–10.O’Keefe S.J., Buchman AL, Fishbain TM et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin. Gastroenterol Hepatol 2006; 4 (1): 6–10.Buchman AL, Scolapio J., Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124 (4): 1111–1134.Buchman AL, Scolapio J., Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124 (4): 1111–1134.Nightingale J., Woodward JM. Small bowel and Nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel. Gut 2006; 55 (suppl 4): iv1–iv12).Nightingale J., Woodward JM. Small bowel and Nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel. Gut 2006; 55 (suppl 4): iv1–iv12).Hotstetter S., Stern L., Willet J. Key issues in addressing the clinical аnd humanistic burden of short bowel syndrome in the US. Gut Med Res Opin 2013; 29 (5): 495–504.Hotstetter S., Stern L., Willet J. Key issues in addressing the clinical аnd humanistic burden of short bowel syndrome in the US. Gut Med Res Opin 2013; 29 (5): 495–504.Jeppesen P. B. Spectrum of short bowel syndrom in adults: Intestinal insufficiency to Intestinal failure. JPEN J Parenter Enteral Nutr 2014; 38 (1 Suppl): 8S-13S.Jeppesen P. B. Spectrum of short bowel syndrom in adults: Intestinal insufficiency to Intestinal failure. JPEN J Parenter Enteral Nutr 2014; 38 (1 Suppl): 8S-13S.Carlsson E. Bosaeus I., Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003; 22 (5): 445–452).Carlsson E. Bosaeus I., Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr 2003; 22 (5): 445–452).Lovshin, J. and D. J. Drucker, Increase in intestinal absorption and nutrient assimilation. Ped. Diabetes, 1 (1): 49–57, 2001.Lovshin, J. and D. J. Drucker, Increase in intestinal absorption and nutrient assimilation. Ped. Diabetes, 1 (1): 49–57, 2001.Bremholm, L. et al. Scan. The designation of the inventor has not yet been filed. J. Gastro. 44 (3): 314–319, 2009.Bremholm, L. et al. Scan. The designation of the inventor has not yet been filed. J. Gastro. 44 (3): 314–319, 2009.TR Ziegler, K Benfell, RJ Smith, LS Young, E Brown et al. Safety and metabolic effects of L-glu-tamine administration in humans. J Parenter. Enteral Nutr. 23 (6 Suppl): S 174–S 183, 1999.TR Ziegler, K Benfell, RJ Smith, LS Young, E Brown et al. Safety and metabolic effects of L-glu-tamine administration in humans. J Parenter. Enteral Nutr. 23 (6 Suppl): S 174–S 183, 1999.Daniel J. Drucker, Robin P. Boushey, Feng Wang, Mary E. Hill, Patricia L., et al. Biologic Properties and Therapeutic Potential of Glucagon-like Peptide-J Parenter. Enteral Nutr. 23 (5 Suppl): S 98–100, 1999.Daniel J. Drucker, Robin P. Boushey, Feng Wang, Mary E. Hill, Patricia L., et al. Biologic Properties and Therapeutic Potential of Glucagon-like Peptide-J Parenter. Enteral Nutr. 23 (5 Suppl): S 98–100, 1999.Estall and Drucker, Glucagon-like peptide-2. Ann. Rev. Nutr. 26: 391–411, 2006.Estall and Drucker, Glucagon-like peptide-2. Ann. Rev. Nutr. 26: 391–411, 2006.Kaji Т., et al. Intestinal adaptation after a resection is aided by GLP-2 in rats as well. J. Ped. Surgery. 44 (8): 1552–1559, 2009.Kaji Т., et al. Intestinal adaptation after a resection is aided by GLP-2 in rats as well. J. Ped. Surgery. 44 (8): 1552–1559, 2009.Perez, A., et al. Glucagon-Like Peptide 2 Is an Endogenous Mediator of Postresection Intestinal Adaptation- J Parenter. Enteral Nutr. 29 (2): 97–101, 2005.Perez, A., et al. Glucagon-Like Peptide 2 Is an Endogenous Mediator of Postresection Intestinal Adaptation- J Parenter. Enteral Nutr. 29 (2): 97–101, 2005.Kaji Т., et al. The designation of the inventor has not yet been filed EP 2. J. Surg. Res. 152 (2): 271–280, 2009.Kaji Т., et al. The designation of the inventor has not yet been filed EP 2. J. Surg. Res. 152 (2): 271–280, 2009.Katherine J. Rowland1 and Patricia L. Brubaker 1,2. The “cryptic” mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 301: G1–G8, 2011.Katherine J. Rowland1 and Patricia L. Brubaker 1,2. The “cryptic” mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 301: G1–G8, 2011.Li H., Zhonghua Wei Chang. Wai Ke Za Zhi. 9 (1): 67–70, 2006.Li H., Zhonghua Wei Chang. Wai Ke Za Zhi. 9 (1): 67–70, 2006.Garison A. P. Early but not late administration of glucagon-like peptide-2 follow-ing ileocecal resection augments putative intestinal stem cell expantion. Am. J. physiol. Gastrointest. Liver Physiol. 2009. 296: 643–650.Garison A. P. Early but not late administration of glucagon-like peptide-2 follow-ing ileocecal resection augments putative intestinal stem cell expantion. Am. J. physiol. Gastrointest. Liver Physiol. 2009. 296: 643–650.Аверьянова Ю. В. Особенности лечения детей с внепеченочной портальной гипертензией и неудовлетворительными результатами ранее проведенных хирургических коррекций. Автореф. дисс. канд., 2021. 23 с.Averyanova Yu. V. Peculiarities of treatment of children with extrahepatic portal hypertension and unsatisfactory results of previous surgical corrections. Abstract of thesis. diss. cand., 2021. 23 p.Новрузбеков М. С., Олисов О. Д., Гуляев В. А., Луцык К. Н., Магоме-дов К. М. Трансплантация и аутотрансплантация как радикальный метод лечения при нерезектабельных опухолевых и паразитарных заболеваниях печени. Анналы хирургической гепатологии, 2020, том 25, № 4. C. 49–58.Novruzbekov M. S., Olisov O. D., Gulyaev V. A., Lutsyk K. N., Magome-dov K. M. Transplantation and autotransplantation as a radical method of treatment for unresectable tumor and parasitic liver diseases. Annals of Surgical Hepatology, 2020, Volume 25, No. 4. P. 49–58.Boushey R. P., et al. Glucagon-like Peptide (GLP)-2 Reduces Chemotherapy-as-sociated Mortality and Enhances Cell Survival in Cells Expressing a Transfected GLP-2 Receptor1. Cancer Res. 61: 687–693, 2001.Boushey R. P., et al. Glucagon-like Peptide (GLP)-2 Reduces Chemotherapy-as-sociated Mortality and Enhances Cell Survival in Cells Expressing a Transfected GLP-2 Receptor1. Cancer Res. 61: 687–693, 2001.Tavakkolizadeh A, Shen R, Abraham P, et al. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. J Surg Res 2000; 91 (1): 77–82. J. Surg. Res. 91 (1) 77–82, 2000.Tavakkolizadeh A, Shen R, Abraham P, et al. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. J Surg Res 2000; 91 (1): 77–82. J. Surg. Res. 91 (1) 77–82, 2000.Booth С., Booth D., Williamson S. et al. Teduglutide protects small intestinal stem cells from radiation damage. Cell Proliferation 37 (6): 385–400, 2004.Booth С., Booth D., Williamson S. et al. Teduglutide protects small intestinal stem cells from radiation damage. Cell Proliferation 37 (6): 385–400, 2004.Sandra Torres, Lars Thim, Fabien Milliat, Marie-Catherine Vozenin-Brotons et al. Glucagon-Like Peptide-2 Improves Both Acute and Late Experimental Radiation Enteritis in the Rat – Int J Radiat Oncol Biol Phys. 69 (5): 1563–1571, 2007.Sandra Torres, Lars Thim, Fabien Milliat, Marie-Catherine Vozenin-Brotons et al. Glucagon-Like Peptide-2 Improves Both Acute and Late Experimental Radiation Enteritis in the Rat – Int J Radiat Oncol Biol Phys. 69 (5): 1563–1571, 2007.Beth A. Carter, Susan Hill, Simon Horslan and al. Successful Intestinal Adaptation with Teduglutide in Child with Short Bowel Syndrome (SBS). Poster presentation in 23th ESPEN course of Clinical Nutrition and Metbolic Care. 2014.Beth A. Carter, Susan Hill, Simon Horslan and al. Successful Intestinal Adaptation with Teduglutide in Child with Short Bowel Syndrome (SBS). Poster presentation in 23th ESPEN course of Clinical Nutrition and Metbolic Care. 2014.Robert S. Venick, Simon A. Carter, Beth A. Carter et al. Nutritional Status Maintained with Teduglutide Treatment in Children with Short Bowel Syndrome (SBS). Poster presentation in 23th ESPEN course of Clinical Nutrition and Metabolic Care. 2014.Robert S. Venick, Simon A. Carter, Beth A. Carter et al. Nutritional Status Maintained with Teduglutide Treatment in Children with Short Bowel Syndrome (SBS). Poster presentation in 23th ESPEN course of Clinical Nutrition and Metabolic Care. 2014.

The authors declare that there are no conflicts of interest present.